Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slid 3.81% to $11.11 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.03% to 33,743.84 and the NASDAQ Composite Index falling 0.18% to 11,313.36. This was the stock's second consecutive day of losses. Novavax Inc. closed $90.28 below its 52-week high ($101.39), which the company reached on February 7th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.71% to $169.51, Pfizer Inc. (PFE) rose 0.81% to $45.07, and Merck & Co. Inc. (MRK) rose 0.06% to $108.59. Trading volume (6.7 M) remained 330,628 below its 50-day average volume of 7.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 25, 2023.
(END) Dow Jones Newswires
January 25, 2023 17:14 ET (22:14 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.